Quantitative Structure Activity Relationships for the Glucuronidation of Simple Phenols by Expressed Human UGT1A6 and UGT1A9

UGT1A6 and UGT1A9 have both been demonstrated to rapidly glucuronidate simple phenolic compounds. A series of simple phenols were selected and screened with both isoforms and then used as model substrates for the generation of V max and K m values. UGT1A6 showed a more restricted acceptance of pheno...

Full description

Saved in:
Bibliographic Details
Published inDrug metabolism and disposition Vol. 30; no. 6; pp. 734 - 738
Main Authors ETHELL, Brian T, EKINS, Sean, JIBO WANG, BURCHELL, Brian
Format Journal Article
LanguageEnglish
Published Bethesda, MD American Society for Pharmacology and Experimental Therapeutics 01.06.2002
Subjects
Online AccessGet full text

Cover

Loading…
Abstract UGT1A6 and UGT1A9 have both been demonstrated to rapidly glucuronidate simple phenolic compounds. A series of simple phenols were selected and screened with both isoforms and then used as model substrates for the generation of V max and K m values. UGT1A6 showed a more restricted acceptance of phenolic substrates compared with UGT1A9. However, the affinity of UGT1A6 for these compounds exhibited higher K m values than UGT1A9, although rates of turnover were similar. Molecular surface-weighted holistic invariant molecular descriptors were generated for each substrate and used to produce the first quantitative structure activity relationship models generated for expressed human UGTs. Models relating log of the K m value to the generated descriptors correlated well with the experimental data r 2 value of 0.996 for UGT1A6 and r 2 value of 0.83 for UGT1A9. Cross validation by a leave-one-out method also showed good predictive capability within the subset with a q 2 value of 0.98 for UGT1A6 and q 2 value of 0.73 for UGT1A9. Empirically, UGT1A6 V max decreased as the 4-substituent increased in size, and a trend was observed when UGT1A6 V max was plotted against molecular volume. The larger UGT1A6 substrates were typified by low activity and lower K m values than their smaller counterparts. Extrapolating from this, it was demonstrated that phenols with large 4-substituents, which were not UGT1A6 substrates, could inhibit 4-ethylphenol glucuronidation. The K m values for UGT1A9 showed a similar relationship to UGT1A6 but with much lower K m values and greater variability in range of this value.
AbstractList UGT1A6 and UGT1A9 have both been demonstrated to rapidly glucuronidate simple phenolic compounds. A series of simple phenols were selected and screened with both isoforms and then used as model substrates for the generation of V max and K m values. UGT1A6 showed a more restricted acceptance of phenolic substrates compared with UGT1A9. However, the affinity of UGT1A6 for these compounds exhibited higher K m values than UGT1A9, although rates of turnover were similar. Molecular surface-weighted holistic invariant molecular descriptors were generated for each substrate and used to produce the first quantitative structure activity relationship models generated for expressed human UGTs. Models relating log of the K m value to the generated descriptors correlated well with the experimental data r 2 value of 0.996 for UGT1A6 and r 2 value of 0.83 for UGT1A9. Cross validation by a leave-one-out method also showed good predictive capability within the subset with a q 2 value of 0.98 for UGT1A6 and q 2 value of 0.73 for UGT1A9. Empirically, UGT1A6 V max decreased as the 4-substituent increased in size, and a trend was observed when UGT1A6 V max was plotted against molecular volume. The larger UGT1A6 substrates were typified by low activity and lower K m values than their smaller counterparts. Extrapolating from this, it was demonstrated that phenols with large 4-substituents, which were not UGT1A6 substrates, could inhibit 4-ethylphenol glucuronidation. The K m values for UGT1A9 showed a similar relationship to UGT1A6 but with much lower K m values and greater variability in range of this value.
UGT1A6 and UGT1A9 have both been demonstrated to rapidly glucuronidate simple phenolic compounds. A series of simple phenols were selected and screened with both isoforms and then used as model substrates for the generation of V(max) and K(m) values. UGT1A6 showed a more restricted acceptance of phenolic substrates compared with UGT1A9. However, the affinity of UGT1A6 for these compounds exhibited higher K(m) values than UGT1A9, although rates of turnover were similar. Molecular surface-weighted holistic invariant molecular descriptors were generated for each substrate and used to produce the first quantitative structure activity relationship models generated for expressed human UGTs. Models relating log of the K(m) value to the generated descriptors correlated well with the experimental data r(2) value of 0.996 for UGT1A6 and r(2) value of 0.83 for UGT1A9. Cross validation by a leave-one-out method also showed good predictive capability within the subset with a q(2) value of 0.98 for UGT1A6 and q(2) value of 0.73 for UGT1A9. Empirically, UGT1A6 V(max) decreased as the 4-substituent increased in size, and a trend was observed when UGT1A6 V(max) was plotted against molecular volume. The larger UGT1A6 substrates were typified by low activity and lower K(m) values than their smaller counterparts. Extrapolating from this, it was demonstrated that phenols with large 4-substituents, which were not UGT1A6 substrates, could inhibit 4-ethylphenol glucuronidation. The K(m) values for UGT1A9 showed a similar relationship to UGT1A6 but with much lower K(m) values and greater variability in range of this value.
Author Brian T. Ethell
Brian Burchell
Jibo Wang
Sean Ekins
Author_xml – sequence: 1
  givenname: Brian T
  surname: ETHELL
  fullname: ETHELL, Brian T
  organization: Department of Molecular and Cellular Pathology, Ninewells Hospital and Medical School, Dundee, United Kingdom
– sequence: 2
  givenname: Sean
  surname: EKINS
  fullname: EKINS, Sean
  organization: Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, indiana, United States
– sequence: 3
  surname: JIBO WANG
  fullname: JIBO WANG
  organization: Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, indiana, United States
– sequence: 4
  givenname: Brian
  surname: BURCHELL
  fullname: BURCHELL, Brian
  organization: Department of Molecular and Cellular Pathology, Ninewells Hospital and Medical School, Dundee, United Kingdom
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13680040$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12019203$$D View this record in MEDLINE/PubMed
BookMark eNpFkE1v1DAQhi1URLeFG2fkCz2RZRw7zvq4qsoWqRIfbSVuluOMG6PEDnYCrMSPJ7Ar7WlG8z56R3ouyFmIAQl5zWDNWCnet0O75rCW65qLZ2TFqpIVAOrbGVktAwpVVfKcXOT8HYAJwdULcs5KYKoEviJ_vswmTH4yk_-J9H5Ks53mhHRrl4Of9vQr9ksWQ-78mKmLiU4d0l0_2znF4Nv_IY2O3vth7JF-7jDEPtNmT29-jwlzxpbezoMJ9HH3wLaSmtAeVvWSPHemz_jqOC_J44ebh-vb4u7T7uP19q6wXNRTwU2Ntq1qaRVwJzdOSFC8hqpUZd0qLlxVGsYqZ5zBDTC3aThKBw3UdcOk4Jfk6tA7pvhjxjzpwWeLfW8CxjnrmklViQoW8N0BtCnmnNDpMfnBpL1moP_Z1ottzUFLvdhe8DfH3rkZsD3BR70L8PYImGxN75IJ1ucTx-UGQMCJ6_xT98sn1GNn0mBs7OPT_vTwL9TUlsQ
CODEN DMDSAI
CitedBy_id crossref_primary_10_1080_00498250310001602757
crossref_primary_10_1146_annurev_pharmtox_44_101802_121546
crossref_primary_10_1210_me_2007_0150
crossref_primary_10_1080_15384047_2015_1026480
crossref_primary_10_1124_dmd_32_8_862
crossref_primary_10_1016_j_jmgm_2004_03_011
crossref_primary_10_3109_00498254_2014_898808
crossref_primary_10_1093_toxsci_kfx054
crossref_primary_10_1517_17425250903179300
crossref_primary_10_1124_dmd_104_002527
crossref_primary_10_1097_01_fpc_0000114771_78957_cb
crossref_primary_10_3109_03602532_2013_767345
crossref_primary_10_1211_jpp_61_10_0006
crossref_primary_10_1021_ci600248e
crossref_primary_10_1039_c1md00140j
crossref_primary_10_3389_fphar_2019_00631
crossref_primary_10_1093_bioinformatics_btt681
crossref_primary_10_3109_00498254_2012_663515
crossref_primary_10_1124_jpet_110_175356
crossref_primary_10_1016_S1359_6446_03_03008_3
crossref_primary_10_1021_cr030440j
crossref_primary_10_1124_dmd_31_11_1361
crossref_primary_10_1021_ci400577a
crossref_primary_10_1080_00498250601129109
crossref_primary_10_1155_2018_6852857
crossref_primary_10_1021_acs_jcim_5b00143
crossref_primary_10_1093_jb_mvs078
crossref_primary_10_1517_17425255_1_2_303
crossref_primary_10_1124_dmd_120_000030
crossref_primary_10_1016_j_ecoenv_2024_116281
crossref_primary_10_1211_jpp_59_6_0007
crossref_primary_10_1039_C5RA20213B
crossref_primary_10_1124_dmd_114_060681
Cites_doi 10.2165/00003088-199732030-00004
10.1002/qsar.19970160203
10.1042/bj1510131
10.1016/0009-2797(94)90110-4
10.1073/pnas.85.22.8381
10.1002/cem.1180080405
10.1002/prot.340180111
10.1042/bj3030233
10.1002/(SICI)1521-3838(200002)19:1<29::AID-QSAR29>3.0.CO;2-P
10.1006/abio.1997.2443
10.1002/jps.2600801013
10.1016/0003-9861(68)90038-6
10.1016/S0021-9258(19)52451-6
10.1016/0005-2744(76)90324-7
10.1016/0898-5529(90)90156-3
10.1042/bj2780465
10.1006/abbi.1994.1157
10.1042/bj0520416
10.3109/00498259109039459
10.1097/00008571-199708000-00001
ContentType Journal Article
Copyright 2002 INIST-CNRS
Copyright_xml – notice: 2002 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1124/dmd.30.6.734
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-009X
EndPage 738
ExternalDocumentID 10_1124_dmd_30_6_734
12019203
13680040
30_6_734
Genre Journal Article
GroupedDBID -
08R
0R
2WC
53G
5GY
5RE
5VS
AAPBV
AAWZA
ABFLS
ABSGY
ACGFS
ACIWK
ACPRK
ADACO
AENEX
AFFNX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FH7
FRP
GJ
GX1
H13
HZ
IH2
INIJC
KM
KQ8
LSO
O0-
O9-
OK1
P2P
R0Z
RHF
RHI
RPT
SJN
VH1
W2D
WH7
WOQ
ZGI
ZXP
---
.GJ
0R~
18M
4.4
ABSQV
ACGFO
ADBBV
AFOSN
AI.
BAWUL
BTFSW
F9R
HZ~
IQODW
TR2
W8F
YCJ
YHG
~KM
ABJNI
ABLYK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c347t-3a7ecd576c903f68f460937052927d934f52a115fafae801f8b3e6f0b077b1643
ISSN 0090-9556
IngestDate Fri Aug 16 21:46:13 EDT 2024
Fri Aug 23 02:56:11 EDT 2024
Thu May 23 23:54:32 EDT 2024
Sun Oct 22 16:05:58 EDT 2023
Tue Jan 05 21:17:00 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Human
Substrate
Structure activity relation
UDP-glucuronosyltransferase
Enzyme
Isozyme
Transferases
Glycosyltransferases
Phenols
Glucuronic acid conjugation
Hexosyltransferases
Quantitative analysis
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c347t-3a7ecd576c903f68f460937052927d934f52a115fafae801f8b3e6f0b077b1643
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 12019203
PQID 71695450
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_71695450
crossref_primary_10_1124_dmd_30_6_734
pubmed_primary_12019203
pascalfrancis_primary_13680040
highwire_pharmacology_30_6_734
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 2002-06-01
PublicationDateYYYYMMDD 2002-06-01
PublicationDate_xml – month: 06
  year: 2002
  text: 2002-06-01
  day: 01
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
PublicationTitle Drug metabolism and disposition
PublicationTitleAlternate Drug Metab Dispos
PublicationYear 2002
Publisher American Society for Pharmacology and Experimental Therapeutics
Publisher_xml – name: American Society for Pharmacology and Experimental Therapeutics
References Green (2019091113321301000_30.6.734.12) 1994; 22
Illing (2019091113321301000_30.6.734.17) 1976; 429
Cheng (2019091113321301000_30.6.734.4) 1999; 27
2019091113321301000_30.6.734.2
Green (2019091113321301000_30.6.734.13) 1996; 24
Senafi (2019091113321301000_30.6.734.26) 1994; 303
2019091113321301000_30.6.734.8
2019091113321301000_30.6.734.7
2019091113321301000_30.6.734.29
2019091113321301000_30.6.734.28
2019091113321301000_30.6.734.27
Schaefer (2019091113321301000_30.6.734.25) 1981; 16
2019091113321301000_30.6.734.31
Gasteiger (2019091113321301000_30.6.734.10) 1990; 3
Coffman (2019091113321301000_30.6.734.5) 1998; 26
Wooster (2019091113321301000_30.6.734.30) 1991; 278
2019091113321301000_30.6.734.19
2019091113321301000_30.6.734.18
2019091113321301000_30.6.734.16
2019091113321301000_30.6.734.15
2019091113321301000_30.6.734.14
2019091113321301000_30.6.734.24
2019091113321301000_30.6.734.22
2019091113321301000_30.6.734.21
Bertz (2019091113321301000_30.6.734.1) 1997; 32
Fournel-Gigleux (2019091113321301000_30.6.734.9) 1990; 39
Bray (2019091113321301000_30.6.734.3) 1952; 52
Mulder (2019091113321301000_30.6.734.23) 1975; 15
Green (2019091113321301000_30.6.734.11) 1998; 26
Ebner (2019091113321301000_30.6.734.6) 1993; 20
Lowry (2019091113321301000_30.6.734.20) 1951; 193
References_xml – volume: 32
  start-page: 210
  year: 1997
  ident: 2019091113321301000_30.6.734.1
  article-title: Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-199732030-00004
  contributor:
    fullname: Bertz
– volume: 24
  start-page: 356
  year: 1996
  ident: 2019091113321301000_30.6.734.13
  article-title: Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein.
  publication-title: Drug Metab Dispos
  contributor:
    fullname: Green
– ident: 2019091113321301000_30.6.734.28
  doi: 10.1002/qsar.19970160203
– volume: 15
  start-page: 131
  year: 1975
  ident: 2019091113321301000_30.6.734.23
  article-title: A rapid NAD+ linked assay for microsomal uridine diphosphate glucuronosyltransferase of rat liver and some observations on substrate specificity of the enzyme.
  publication-title: Biochem J
  doi: 10.1042/bj1510131
  contributor:
    fullname: Mulder
– volume: 39
  start-page: 177
  year: 1990
  ident: 2019091113321301000_30.6.734.9
  article-title: Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell culture.
  publication-title: Mol Pharmacol
  contributor:
    fullname: Fournel-Gigleux
– volume: 27
  start-page: 1165
  year: 1999
  ident: 2019091113321301000_30.6.734.4
  article-title: Studies on the substrate specificity of human intestinal UDP-glucuronosyltransferases 1A8 and 1A10.
  publication-title: Drug Metab and Dispos
  contributor:
    fullname: Cheng
– volume: 16
  start-page: 461
  year: 1981
  ident: 2019091113321301000_30.6.734.25
  article-title: Structure-activity relationships in glucuronidation of substituted phenols.
  publication-title: Eur J Med Chem
  contributor:
    fullname: Schaefer
– ident: 2019091113321301000_30.6.734.31
  doi: 10.1016/0009-2797(94)90110-4
– ident: 2019091113321301000_30.6.734.16
  doi: 10.1073/pnas.85.22.8381
– ident: 2019091113321301000_30.6.734.29
  doi: 10.1002/cem.1180080405
– volume: 20
  start-page: 50
  year: 1993
  ident: 2019091113321301000_30.6.734.6
  article-title: Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family.
  publication-title: Drug Metab Dispos
  contributor:
    fullname: Ebner
– ident: 2019091113321301000_30.6.734.19
  doi: 10.1002/prot.340180111
– volume: 303
  start-page: 233
  year: 1994
  ident: 2019091113321301000_30.6.734.26
  article-title: Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.
  publication-title: Biochem J
  doi: 10.1042/bj3030233
  contributor:
    fullname: Senafi
– ident: 2019091113321301000_30.6.734.2
  doi: 10.1002/(SICI)1521-3838(200002)19:1<29::AID-QSAR29>3.0.CO;2-P
– ident: 2019091113321301000_30.6.734.8
  doi: 10.1006/abio.1997.2443
– ident: 2019091113321301000_30.6.734.18
  doi: 10.1002/jps.2600801013
– volume: 22
  start-page: 799
  year: 1994
  ident: 2019091113321301000_30.6.734.12
  article-title: Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroids and xenobiotics.
  publication-title: Drug Metab and Dispos
  contributor:
    fullname: Green
– ident: 2019091113321301000_30.6.734.14
  doi: 10.1016/0003-9861(68)90038-6
– volume: 193
  start-page: 265
  year: 1951
  ident: 2019091113321301000_30.6.734.20
  article-title: Protein measurement with folin phenol reagent.
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)52451-6
  contributor:
    fullname: Lowry
– volume: 429
  start-page: 768
  year: 1976
  ident: 2019091113321301000_30.6.734.17
  article-title: Observations on the accessibility of acceptor substrates to the active centre of UDP-glucuronosyltransferase in vitro.
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0005-2744(76)90324-7
  contributor:
    fullname: Illing
– volume: 3
  start-page: 537
  year: 1990
  ident: 2019091113321301000_30.6.734.10
  article-title: Automatic generation of 3D atomic coordinates for organic molecules.
  publication-title: Tetrahedron Comput Methodol
  doi: 10.1016/0898-5529(90)90156-3
  contributor:
    fullname: Gasteiger
– volume: 26
  start-page: 507
  year: 1998
  ident: 2019091113321301000_30.6.734.11
  article-title: Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.
  publication-title: Drug Metab and Dispos
  contributor:
    fullname: Green
– ident: 2019091113321301000_30.6.734.15
– volume: 278
  start-page: 465
  year: 1991
  ident: 2019091113321301000_30.6.734.30
  article-title: Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronsyltransferase cDNA family.
  publication-title: Biochem J
  doi: 10.1042/bj2780465
  contributor:
    fullname: Wooster
– volume: 26
  start-page: 73
  year: 1998
  ident: 2019091113321301000_30.6.734.5
  article-title: The glucuronidation of opioids, other xenobiotics and androgens by human UGT2B7Y(268) and UGT2B7H(268).
  publication-title: Drug Metab and Dispos
  contributor:
    fullname: Coffman
– ident: 2019091113321301000_30.6.734.24
  doi: 10.1006/abbi.1994.1157
– volume: 52
  start-page: 416
  year: 1952
  ident: 2019091113321301000_30.6.734.3
  article-title: Kinetic studies on the metabolism of foreign organic compounds 3. The conjugation of phenols with glucuronic acid.
  publication-title: Biochem J
  doi: 10.1042/bj0520416
  contributor:
    fullname: Bray
– ident: 2019091113321301000_30.6.734.7
– ident: 2019091113321301000_30.6.734.22
– ident: 2019091113321301000_30.6.734.27
  doi: 10.3109/00498259109039459
– ident: 2019091113321301000_30.6.734.21
  doi: 10.1097/00008571-199708000-00001
SSID ssj0014439
Score 1.9442759
Snippet UGT1A6 and UGT1A9 have both been demonstrated to rapidly glucuronidate simple phenolic compounds. A series of simple phenols were selected and screened with...
UGT1A6 and UGT1A9 have both been demonstrated to rapidly glucuronidate simple phenolic compounds. A series of simple phenols were selected and screened with...
SourceID proquest
crossref
pubmed
pascalfrancis
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 734
SubjectTerms Biological and medical sciences
Cell Line
General pharmacology
Glucuronides - metabolism
Glucuronosyltransferase - metabolism
Humans
Isoenzymes - metabolism
Kinetics
Medical sciences
Molecular Structure
Pharmacology. Drug treatments
Phenols - chemistry
Phenols - metabolism
Phenols - pharmacokinetics
Physicochemical properties. Structure-activity relationships
Quantitative Structure-Activity Relationship
Title Quantitative Structure Activity Relationships for the Glucuronidation of Simple Phenols by Expressed Human UGT1A6 and UGT1A9
URI http://dmd.aspetjournals.org/content/30/6/734.abstract
https://www.ncbi.nlm.nih.gov/pubmed/12019203
https://search.proquest.com/docview/71695450
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKcuGCeFMeiw-wFzYltR27OVaw7GoRqKu2orfIThwaUdJq20gU8YP4mYwTx0mXIi1cIjeJnbbfl_GMZzyD0EsdpFIkA-5JSmOPpQHxFA-U1w8kTD9xHIuyZuTHT_xsys5nwazT-dWKWio2qhf_2Luv5H9QhXOAq9kl-w_IukHhBLQBXzgCwnC8FsYXhczLTWIm_GdcZoI1_oBhbEtCuEi3ebZau4DC00URFyYlbuLUxXFmkgS_Hs11vlysjUp68r2MkAV1tFrmn55O-kNeuhrKZtjWat9dFl9MLWog1KIuupFkLiDMae2bee3luDRyZdJzV77aZe-xbtj62S5ln2dq6VYNTO2q9iA7qxakia6qJXHoe2EQ2DTYVviSvgcXZm3pbL022R-iVthFUG0_DfZPCIQBism3pEf9Hu-5Tu2821fmQxelWNpHhEXQO6J-xCPofQPdJCIMjJn_4aLxVzFGK0PL_qp6iwVhb9rP3lV-6oTUJh5XruGVTKtaKn83dkqlZ3IH3bbWCh5W1LuLOjq_h45GVbrz7TGeNLv31sf4CI-aROjb--hnm5_Y8RPX_MQ7_MTATwwMwVf4iZcprviJLT-x2mLHT1zyE1f8xMC8qhk-QNP3J5O3Z56t9uHFlImNR6XQcQLmbxz6NOWDlHEfdGfjiSYiCamRIxLsl1SmUoNelQ4U1Tz1lS-EAqOfPkQH-TLXjxEWoHhyrXVfqoRpX4UqAEM4kCFJpJCMdNGrGoZoVSV1ifaB3UWHNUbRqvUHtm_YQa4ZjfKBmR-76EUNZQRy2zjjZK6XxToyWarAeoE7HlUIN32JMbt8-uSa3_IputW8Yc_QAaCpn4OmvFGHJUl_AwO9wX0
link.rule.ids 315,786,790,27957,27958
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitative+Structure+Activity+Relationships+for+the+Glucuronidation+of+Simple+Phenols+by+Expressed+Human+UGT1A6+and+UGT1A9&rft.jtitle=Drug+metabolism+and+disposition&rft.au=Ethell%2C+Brian+T.&rft.au=Ekins%2C+Sean&rft.au=Wang%2C+Jibo&rft.au=Burchell%2C+Brian&rft.date=2002-06-01&rft.issn=0090-9556&rft.eissn=1521-009X&rft.volume=30&rft.issue=6&rft.spage=734&rft.epage=738&rft_id=info:doi/10.1124%2Fdmd.30.6.734&rft.externalDBID=n%2Fa&rft.externalDocID=10_1124_dmd_30_6_734
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-9556&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-9556&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-9556&client=summon